Institution
University of Bath
Education•Bath, Bath and North East Somerset, United Kingdom•
About: University of Bath is a education organization based out in Bath, Bath and North East Somerset, United Kingdom. It is known for research contribution in the topics: Population & Context (language use). The organization has 15830 authors who have published 39608 publications receiving 1358769 citations. The organization is also known as: Bath University.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: This discussion paper argues for a creative synthesis between simulation and clinical practice, where an iterative process of continual interaction ensures that skills are learned and reinforced within the context of everyday professional life.
Abstract: INTRODUCTION This discussion paper argues for a creative synthesis between simulation and clinical practice, where an iterative process of continual interaction ensures that skills are learned and reinforced within the context of everyday professional life. BACKGROUND Evidence is mounting that long-established approaches to surgical training are no longer acceptable in the current ethical and professional climate. This paper considers alternatives to the traditional approach of 'learning by doing' in a clinical context, focusing on recent developments in the technology of simulation and virtual reality. Clinical expertise is a complex phenomenon and no single theory can account for its acquisition. After a brief contextualising overview, Vygotsky's 'zone of proximal development' is proposed as a conceptual framework for task-based surgical learning that takes place within skills laboratories. The discussion is located within a wider context of educational theory, drawing on current thinking about situated learning and apprenticeship. The notion of 'legitimate peripheral participation' in a complex professional environment places technical skill alongside a range of other competencies that are necessary to safe practice. CONCLUSIONS Simulation offers a safe environment within which learners can repeatedly practise a range of clinical skills without endangering patients. Comprehensive simulated environments allow a move away from isolated tasks to more complex clinical situations, recreating many of the challenges of real life. Such simulations, however, can operate in isolation from their clinical context, ignoring the learning needs of individuals within a real health care environment. To realise its full potential as a learning aid, simulation must be used alongside clinical practice and linked closely with it.
397 citations
••
TL;DR: In this paper, an integrative model examining the relationships among relational, structural and cognitive dimensions of social capital, and between these dimensions and the cost and innovation performance of the firm was proposed.
396 citations
••
TL;DR: In this paper, the techniques of neutron diffraction and x-ray diffraction, as applied to structural studies of liquids and glasses, are reviewed, with an emphasis on the explanation and discussion of the experimental techniques and data analysis methods, as illustrated by the results of representative experiments.
Abstract: The techniques of neutron diffraction and x-ray diffraction, as applied to structural studies of liquids and glasses, are reviewed. Emphasis is placed on the explanation and discussion of the experimental techniques and data analysis methods, as illustrated by the results of representative experiments. The disordered, isotropic nature of the structure of liquids and glasses leads to special considerations and certain difficulties when neutron and x-ray diffraction techniques are applied, especially when used in combination on the same system. Recent progress in experimental technique, as well as in data analysis and computer simulation, has motivated the writing of this review.
395 citations
••
TL;DR: The impact of Drosophila genetics on the field of insect resistance and the current and future impact of genomics is reviewed and three fundamental questions in the evolution of resistance are addressed.
395 citations
••
University College London1, Alzheimer's Society2, University of Cambridge3, University of Sheffield4, Brighton and Sussex Medical School5, Bangor University6, Imperial College London7, Ludwig Maximilian University of Munich8, Technische Universität München9, Oxford Health NHS Foundation Trust10, University of Hertfordshire11, University of Manchester12, Cardiff University13, University of East Anglia14, University of Bath15, University of Warwick16, University of Hull17, University of Nottingham18, University of Oxford19, Leeds Beckett University20, University of Exeter21, Wolfson Centre for Age-Related Diseases22, St George's, University of London23, University of Bristol24, Queen's University Belfast25, University of Southampton26, Aston University27, Newcastle University28, Camden and Islington NHS Foundation Trust29
TL;DR: This is the first review to identify the 81 outcome measures the research community uses for disease-modifying trials in mild-to-moderate dementia, and recommended core outcomes were cognition as the fundamental deficit in dementia and to indicate disease modification, serial structural MRIs.
Abstract: Background There are no disease-modifying treatments for dementia. There is also no consensus on disease modifying outcomes. We aimed to produce the first evidence-based consensus on core outcome measures for trials of disease modification in mild-to-moderate dementia. Methods and findings We defined disease-modification interventions as those aiming to change the underlying pathology. We systematically searched electronic databases and previous systematic reviews for published and ongoing trials of disease-modifying treatments in mild-to-moderate dementia. We included 149/22,918 of the references found; with 81 outcome measures from 125 trials. Trials involved participants with Alzheimer’s disease (AD) alone (n = 111), or AD and mild cognitive impairment (n = 8) and three vascular dementia. We divided outcomes by the domain measured (cognition, activities of daily living, biological markers, neuropsychiatric symptoms, quality of life, global). We calculated the number of trials and of participants using each outcome. We detailed psychometric properties of each outcome. We sought the views of people living with dementia and family carers in three cities through Alzheimer’s society focus groups. Attendees at a consensus conference (experts in dementia research, disease-modification and harmonisation measures) decided on the core set of outcomes using these results. Recommended core outcomes were cognition as the fundamental deficit in dementia and to indicate disease modification, serial structural MRIs. Cognition should be measured by Mini Mental State Examination or Alzheimer's Disease Assessment Scale-Cognitive Subscale. MRIs would be optional for patients. We also made recommendations for measuring important, but non-core domains which may not change despite disease modification. Limitations Most trials were about AD. Specific instruments may be superseded. We searched one database for psychometric properties. Interpretation This is the first review to identify the 81 outcome measures the research community uses for disease-modifying trials in mild-to-moderate dementia. Our recommendations will facilitate designing, comparing and meta-analysing disease modification trials in mild-to-moderate dementia, increasing their value.
394 citations
Authors
Showing all 16056 results
Name | H-index | Papers | Citations |
---|---|---|---|
Michael Grätzel | 248 | 1423 | 303599 |
Brenda W.J.H. Penninx | 170 | 1139 | 119082 |
Amartya Sen | 149 | 689 | 141907 |
Gilbert Laporte | 128 | 730 | 62608 |
Andre K. Geim | 125 | 445 | 206833 |
Matthew Jones | 125 | 1161 | 96909 |
Benoît Roux | 120 | 493 | 62215 |
Stephen Mann | 120 | 669 | 55008 |
Bruno S. Frey | 119 | 900 | 65368 |
Raymond A. Dwek | 118 | 603 | 52259 |
David Cutts | 114 | 778 | 64215 |
John Campbell | 107 | 1150 | 56067 |
David Chandler | 107 | 424 | 52396 |
Peter H.R. Green | 106 | 843 | 60113 |
Huajian Gao | 105 | 667 | 46748 |